Published in
Nature Research, Nature Genetics, 2(51), p. 207-216, 2018
DOI: 10.1038/s41588-018-0287-5
Links
Tools
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
Journal article published in 2018 by
Utthara Nayar,
Ofir Cohen,
Christian Kapstad,
Michael S. Cuoco,
Adrienne G. Waks 
,
Seth A. Wander,
Corrie Painter,
Samuel Freeman ,
Nicole S. Persky,
Lori Marini,
Karla Helvie,
Nelly Oliver,
Orit Rozenblatt-Rosen,
Cynthia X. Ma,
Aviv Regev
and other authors.
,
Seth A. Wander,
Corrie Painter,
Samuel Freeman ,
Nicole S. Persky,
Lori Marini,
Karla Helvie,
Nelly Oliver,
Orit Rozenblatt-Rosen,
Cynthia X. Ma,
Aviv Regev
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 